IP Verse

Pcv/Mycoplasma Hyopneumoniae Combination Vaccine - EP2833910

The patent EP2833910 was granted to Zoetis on Feb 13, 2019. The application was originally filed on Apr 3, 2013 under application number EP13718432A. The patent is currently recorded with a legal status of "Revoked".

EP2833910

ZOETIS
Application Number
EP13718432A
Filing Date
Apr 3, 2013
Status
Revoked
Apr 27, 2024
Grant Date
Feb 13, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BOEHRINGER INGELHEIM ANIMAL HEALTH USAApr 4, 2019D YOUNGADMISSIBLE

Patent Citations (47) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2011IB55003
DESCRIPTIONEP0595436
DESCRIPTIONGB2282811
DESCRIPTIONUS2011150913
DESCRIPTIONUS5620691
DESCRIPTIONUS5695766
DESCRIPTIONUS5788962
DESCRIPTIONUS6110467
DESCRIPTIONUS6162435
DESCRIPTIONUS6165995
DESCRIPTIONUS6251397
DESCRIPTIONUS6251404
DESCRIPTIONUS6268199
DESCRIPTIONUS6380376
DESCRIPTIONUS6500662
DESCRIPTIONUS6592873
DESCRIPTIONUS6610310
DESCRIPTIONUS6773908
DESCRIPTIONUS6977078
DESCRIPTIONUS7223854
DESCRIPTIONUS7264802
DESCRIPTIONUS7264957
DESCRIPTIONUS7279166
DESCRIPTIONUS7419806
DESCRIPTIONUS7517976
DESCRIPTIONUS7575752
DESCRIPTIONWO03049703
DESCRIPTIONWO9221375
DESCRIPTIONWO9303760
DESCRIPTIONWO9307898
DESCRIPTIONWO9314196
INTERNATIONAL-SEARCH-REPORTWO2007116032
INTERNATIONAL-SEARCH-REPORTWO2009126356
INTERNATIONAL-SEARCH-REPORTWO2011141443
INTERNATIONAL-SEARCH-REPORTWO9628472
OPPOSITIONEP0283840
OPPOSITIONEP2217271
OPPOSITIONEP2327787
OPPOSITIONUS2009317423
OPPOSITIONUS2012052514
OPPOSITIONUS8546149
OPPOSITIONUS9599607
OPPOSITIONUS9687544
OPPOSITIONWO2009126356
OPPOSITIONWO2009127684
OPPOSITIONWO2012025612
OPPOSITIONWO9628472

Non-Patent Literature (NPL) Citations (31) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
OPPOSITION- ALLAN et al., "Porcine Circoviruses: A Review", J. Vet. Diagn. Invest., (20000000), vol. 12, pages 3 - 14, XP001023034
OPPOSITION- Antibody Purification Handbook, AMERSHAM BIOSCIENCES,, pages FP - 107, XP002357261
OPPOSITION- "Committee for Human Medicinal Products (CHMP) notes for guidance of the clinical evaluation of vaccines", EMEA (CHMP/VWP/164653/2005), (20050000), pages 1 - 23, XP055565795
OPPOSITION- EICHMEYER et al., "Efficacy of Ingelvac® PRRS MLV when rehydrated with a combination of Ingelvac MycoFLEX® and Ingelvac CircoFLEX®", Allen D. Leman Swine Conference, (20100000), page 153, XP055565896
OPPOSITION- GRAU-ROMA et al., "Recent advances in the epidemiology, diagnosis and control of diseases caused by porcine circovirus type 2", The Veterinary Journal, (20110000), vol. 187, pages 23 - 32, XP027570489
OPPOSITION- "Guidance of Industry for the Evaluation of combination vaccines for preventable diseases: production, testing and clinical studies", U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research, (19970400), pages 1 - 19, XP055584273
OPPOSITION- HAIWICK et al., "Trivalent vaccine mixture protects against simultaneous challenge with M. hyopneumoniae, PCV2, and PRRS virus", Allen D. Leman Swine Conference, (20100000), page 176, XP055565903
OPPOSITION- "Ingelvac CircoFLEX-MycoFLEX Material Safety Data Sheet", Boehringer Ingelheim, (20080623), XP055306404
OPPOSITION- KAISER et al., "Mycoplasma hyopneumoniae efficacy and field safety evaluation of a 3-way Haemophilus parasuis/Mycoplasma hyopneumoniae combination bacterin", Conference paper , Allen D. Leman Swine Conference, (20080000), page 31, XP055565848
OPPOSITION- KRICKA LJ, "Interferences in Immunoassay - Still a Threat", Clin. Chem., (20000000), vol. 46, pages 1037 - 1038, XP055321256
OPPOSITION- LAM, "Serologic and immunologic studies on Mycoplasma hyopneumoniae pneumonia of swine", Retrospective Theses and Dissertations 4178, (19700000), pages FP - 118, XP055565998
OPPOSITION- Neuberger et al., "Innovation and Technology Contributing to the Development of Fostera.TM. PCV MH", Zoetis Technical update, (20131000), XP055565772
OPPOSITION- "New Advancements in the Control of Erysipelas and Mycoplasma Pneumonia", INTERVIEW, (20050000), XP055584421
OPPOSITION- O'DEA, "Porcine circovirus infection", Zealand Standard Diagnostic Procedure, (20100000), pages 1 - 20, XP055565863
OPPOSITION- "Porcine Respiratory Disease Complex", The Pig Site, (20090212), XP055565799
OPPOSITION- QUILITIS et al., "Serological response to PRRSvaccination using a mycoplasma bacterin (MYPRA.VAOID SUIS) as diluents for a live attenuated PRRSV vaccine "AMERAVAC(R)PRRS"", proceedings of the 21st IPVS Congress, Vancouver, Canada, (20100718), XP055584410
OPPOSITION- "Responsible use of vaccines and vaccination in pig production", RUMA Guidelines, (20061100), pages 1 - 24, XP055565889
OPPOSITION- RICE et al., "G86-797 Causes of Vaccination-Immunization Failures in Livestock", Historical Materials, (19860000), pages 1 - 6, URL: https://diqitalcommons.unl.edu/extensionhist/229, XP055566051
OPPOSITION- Straw et al., "Chapters 7 and 14", Diseases of Swine, (20060000), pages 164 - 171,298-307, XP055565968
OPPOSITION- LINDMARK et al., "Binding of immunoglobulins to protein A and immunoglobulin levels in mammalian sera", J Immunol Methods, (19830000), vol. 62, pages 1 - 13, XP023973877
OPPOSITION- FREUNDT, "Culture Media cor Classic Mycoplasms", Methods in Mycoplasmology, (19830000), vol. C7, pages 127 - 135, XP055321252
OPPOSITION- OKADA et al., "Cytological and immunological changes in bronchoalveolar lavage fluid and histological observation of lung lesions in pigs immunized with Mycoplasma hyopneumoniae inactivated vaccine prepared from broth culture supernate", Vaccine, (20000000), vol. 18, pages 2825 - 2831, XP004203572
OPPOSITION- CHEN et al., "Identification of a novel adhesin-like glycoprotein from Mycoplasma hyopneumoniae", Veterinary Microbiology, (19980000), vol. 62, pages 97 - 110, XP055565992
OPPOSITION- CHEN et al., "Identification of the copper-zinc superoxide dismutase activity in Mycoplasma hyopneumoniae", Veterinary Microbiology, (20000000), vol. 73, pages 301 - 310, XP055565974
OPPOSITION- OKADA et al., "Protective Effect of Vaccination with Culture Supernate of M. hyopneumoniae against Experimental Infection in Pigs", J. Vet. Med., (20000000), vol. 47, no. 7, pages 527 - 533, XP055067074
OPPOSITION- GILLESPIE et al., "Porcine Circovirus Type 2 and Porcine Circovirus-Associated Disease", J. Vet. Intern Med., (20090000), vol. 23, pages 1151 - 1163, XP055565869
OPPOSITION- WISE et al., "Major membrane surface proteins of Mycoplasma hyopneumoniae selectively modified by covalently bound lipid", Journal of Bacteriology, (19870000), vol. 169, pages 5546 - 5555, XP001008076
OPPOSITION- SELBY, "Interference in immunoassay", Ann. Clin. Biochem., (19990000), vol. 36, pages 704 - 721, XP055321269
OPPOSITION- OKADA et al., "Evaluation of Mycoplasma hyopneumoniae Inactivated Vaccine in Pigs under Field Conditions", J. Vet. Med. Sci., (19990000), vol. 61, no. 10, pages 1131 - 1135, XP055565881
OPPOSITION- LEFEVRE et al., "Immune Responses in Pigs Vaccinated with Adjuvanted and Non-Adjuvanted A(H1N1)pdm/09 Influenza Vaccines Used in Human Immunization Programmes", PLoS ONE, vol. 7, no. 3, (20120309), pages 1 - 10, URL: 10.1371/journal.pone.0032400, XP055566026
OPPOSITION- ZHANG et al., "Production of recombinant protein G through high-density fermentation of engineered bacteria as well as purification", Mol Med Reports, (20150000), vol. 12, pages 3132 - 3138, XP055584457

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents